INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Acetazolamide use in Acute Exacerbation of COPD with Type 2 Respiratory Failure: Case Reports
Authors Name:
Dr Akshay Singh
, Dr Deepak Gupta , Dr Prashanti Pandey
Unique Id:
IJSDR2410006
Published In:
Volume 9 Issue 10, October-2024
Abstract:
Background:- Acetazolamide is a diuretic and carbonic anhydrase inhibitor medication used to treat several illnesses. It works to cause an accumulation of carbonic acid by preventing its breakdown. FDA-approved indications include glaucoma, idiopathic intracranial hypertension, congestive heart failure, altitude sickness, periodic paralysis, and epilepsy. In addition, it is used off-label for central sleep apnea, Marfan syndrome, prevention of high-dose methotrexate nephrotoxicity, and prevention of contrast-induced nephropathy. Method:- In this study we discussed 3 cases of Acute Exacerbation of COPD with type 2 respiratory failure admitted at Critical care unit Apollo Hospital Bilaspur, These patient were started on acetazolamide 250mg bd along with other supportive treatment. Conclusion:- Acetazolamide appears to improve hypoxemic and hypercapnic COPD patients without any side effects on short term therapy in exacerbation cases along with other supportive treatment.
"Acetazolamide use in Acute Exacerbation of COPD with Type 2 Respiratory Failure: Case Reports", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.9, Issue 10, page no.41 - 45, October-2024, Available :http://www.ijsdr.org/papers/IJSDR2410006.pdf
Downloads:
00058
Publication Details:
Published Paper ID: IJSDR2410006
Registration ID:212535
Published In: Volume 9 Issue 10, October-2024
DOI (Digital Object Identifier):
Page No: 41 - 45
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn